Close

Dr Ebenezer Foster-Nyarko

Research Fellow

United Kingdom

I am a Research Fellow in Professor Kathryn Holt's group at the London School of Hygiene and Tropical Medicine, UK. My current research involves undertaking high-quality computational genomics-based research to elucidate the genetic determinants of AMR and virulence in Klebsiella pneumonia and contributing to research aimed at improving phenotype prediction from genotypic data to enhance genomic surveillance of AMR and virulence in K. pneumoniae. I have a PhD in microbial genomics (Quadram Institute Bioscience and Norwich Medical School, University of East Anglia, Norwich, UK). My PhD research focused on understanding the within-host diversity of Escherichia coli in the vertebrate gut.

Before my PhD, I worked as a Scientific Officer at the Medical Research Council Unit the Gambia at LSHTM, where I was involved in invasive bacterial disease surveillance in the WHO Regional Co-ordinating Centre headed by Professor Martin Antonio.

Aside from my research, I am honoured to serve as the Regional Coordinator for PulseNET Africa, a regional hub of PulseNET International. I also chair the African Pathogen Initiative's Foodborne Diseases Technical Focus Group, helping to shape the future of foodborne disease genomic surveillance in Africa.

Affiliations

Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Research

Microbial genomics, Antimicrobial resistance, Bioinformatics, Klebsiella pneumoniae

Research Area
Bacteria
Drug resistance
Surveillance
Bacteriology
Genomics
Microbiology

Selected Publications

Molecular Epidemiology of Diarrhoeagenic<i>Escherichia coli</i>in Africa: A Systematic Review and Meta-Analysis
Kalule, JB; Bester, LA; Banda, DL; Derra, FA; Chikuse, F; Tessema, SK; FOSTER-NYARKO, E;
2023
Cold Spring Harbor Laboratory
Corrigendum: 'Nanopore-only assemblies for genomic surveillance of the global priority drug-resistant pathogen, Klebsiella pneumoniae'.
FOSTER-NYARKO, E; Cottingham, H; Wick, RR; Judd, LM; Lam, MM C; Wyres, KL; Stanton, TD; Tsang, KK; David, S; Aanensen, DM; Brisse, S; HOLT, KE;
2023
Microbial genomics
Acquisition of a large virulence plasmid (pINV) promoted temperature-dependent virulence and global dispersal of O96:H19 enteroinvasive Escherichia coli.
Miles, SL; Torraca, V; DYSON, ZA; López-Jiménez, AT; FOSTER-NYARKO, E; Lobato-Márquez, D; Jenkins, C; HOLT, KE; MOSTOWY, S;
2023
mBio
Nanopore-only assemblies for genomic surveillance of the global priority drug-resistant pathogen, Klebsiella pneumoniae
FOSTER-NYARKO, E; HOLT, KE; Cottingham, H; Wick, R; Judd, LM; Lam, M; Wyres, KL; Stanton, T; Tsang, KK; David, S; Bridel, S; Palma, F; Aanensen, DM; Brisse, S;
2023
Figshare
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
Cotton, S; McHugh, MP; Dewar, R; Haas, JG; Templeton, K; COVID-19 Genomics UK (COG-UK) Consortium,;
2023
The Journal of hospital infection
Nanopore-only assemblies for genomic surveillance of the global priority drug-resistant pathogen, Klebsiella pneumoniae.
FOSTER-NYARKO, E; Cottingham, H; Wick, RR; Judd, LM; Lam, MM C; Wyres, KL; STANTON, TD; TSANG, KK; David, S; Aanensen, DM; Brisse, S; HOLT, KE;
2023
Microbial genomics
The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021
Eales, O; Page, AJ; Tang, SN; Walters, CE; Wang, H; Haw, D; Trotter, AJ; Le Viet, T; FOSTER-NYARKO, E; Prosolek, S; Atchison, C; Ashby, D; Cooke, G; Barclay, W; Donnelly, CA; O'Grady, J; Volz, E; The Covid-Genomics Uk Cog-Uk Consortium,; Darzi, A; Ward, H; Elliott, P; Riley, S;
2023
Microbial genomics
Acquisition of a large virulence plasmid (pINV) promoted temperature-dependent virulence and global dispersal of O96:H19 enteroinvasive<i>Escherichia coli</i>
Miles, S; Torraca, V; Dyson, Z; López-Jiménez, AT; FOSTER-NYARKO, E; Jenkins, C; Holt, K; MOSTOWY, S;
2022
bioRxiv
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study.
Lo, SW; Mellor, K; Cohen, R; Alonso, AR; Belman, S; Kumar, N; Hawkins, PA; Gladstone, RA; Von Gottberg, A; Veeraraghavan, B; Ravikumar, KL; Kandasamy, R; Pollard, SA J; Saha, SK; Bigogo, G; ANTONIO, M; Kwambana-Adams, B; Mirza, S; Shakoor, S; Nisar, I; Cornick, JE; Lehmann, D; Ford, RL; Sigauque, B; Turner, P; ... Global Pneumococcal Sequencing Consortium,
2022
The Lancet Microbe
Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
Willett, BJ; Grove, J; MacLean, OA; Wilkie, C; De Lorenzo, G; Furnon, W; Cantoni, D; Scott, S; Logan, N; Ashraf, S; Manali, M; Szemiel, A; Cowton, V; Vink, E; Harvey, WT; Davis, C; Asamaphan, P; Smollett, K; Tong, L; Orton, R; Hughes, J; Holland, P; Silva, V; Pascall, DJ; Puxty, K; ... Thomson, EC.
2022
Nature microbiology
See more information